Tóth Anita Réka, Hideg Zsuzsanna, Institóris László
Szegedi Tudományegyetem, Általános Orvostudományi Kar, Szent-Györgyi Albert Orvostudományi Centrum, Igazságügyi Orvostani Intézet Szeged, Kossuth L. sgt. 40. 6724.
Orv Hetil. 2011 Jul 24;152(30):1192-6. doi: 10.1556/OH.2011.29170.
New natural and synthetic compounds are continuously introduced into the illicit drug market. Their origin, composition, main and side-effects are often not exactly known by the users themselves. Thus, the control of these substances is extremely difficult.
In year 2008, a new synthetic drug called mephedrone (2-metilamino-1-(4-metilfenil) propan-1-on) appeared in Hungary. This work summarizes its frequency in biological samples investigated for illicit drugs, and experiences of the medical examination of mephedrone-users.
Toxicological analyses of biological samples (urine and/or blood) were carried by GC-MS at the Institute of National Toxicology and at Department of Forensic Medicine, University Szeged.
Altogether 5386 samples were analyzed in 2010 (4922 in Budapest and 464 in Szeged), and mephedrone was identified in 363 cases (7%).
Mephedrone is banned in Hungary since January 1st, 2011, but it still available in the illegal drug market. At present we do not have sufficient experience with its long-term effects, tolerance, addiction, withdrawal symptoms or toxic dose. Thus, it is difficult to establish whether addiction and/or mental disorder occurred.
新的天然和合成化合物不断涌入非法药物市场。其来源、成分、主要和副作用使用者自己往往并不确切知晓。因此,对这些物质的管控极其困难。
2008年,一种名为甲麻黄碱(2-甲基氨基-1-(4-甲基苯基)丙烷-1-酮)的新型合成药物在匈牙利出现。这项工作总结了其在非法药物检测生物样本中的出现频率,以及对甲麻黄碱使用者进行医学检查的经验。
国家毒理学研究所和塞格德大学法医学系采用气相色谱-质谱联用仪对生物样本(尿液和/或血液)进行毒理学分析。
2010年共分析了5386份样本(布达佩斯4922份,塞格德464份),其中363例(7%)检测出甲麻黄碱。
自2011年1月1日起,甲麻黄碱在匈牙利被禁用,但仍在非法药物市场流通。目前我们对其长期影响、耐受性、成瘾性、戒断症状或中毒剂量尚无足够经验。因此,很难确定是否出现了成瘾和/或精神障碍。